Search research articles
Contact Us
Filters
Showing results (331-340 of 383) with videos related to
Page
of 39
Sort By:
JAMA Surgery
|
October 14, 2020
Optimizing the Implementation of Surgical Coaching Through Feedback From Practicing Surgeons
Jason C Pradarelli, Steven Yule, Nikhil Panda, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 16, 2017
First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288
Kelvin W Gee, Ann Olincy, Richard Kanner, et al.
Annals of the New York Academy of Sciences
|
July 4, 2002
Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancer
R I Nicholson, I R Hutcheson, M E Harper, et al.
Journal of Surgical Education
|
November 4, 2022
Impact of Rater Training on Residents Technical Skill Assessments: A Randomized Trial
Kristen M Jogerst, Yoon Soo Park, Roi Anteby, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1997
CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat
D M Edgar, W F Seidel, K W Gee, et al.
Surgical Endoscopy
|
August 27, 2021
Challenges of virtual interviewing for surgical fellowships: a qualitative analysis of applicant experiences
Roi Anteby, Robert D Sinyard, Kristen M Jogerst, et al.
Annals of Surgery
|
August 3, 2020
Surgeons' Coaching Techniques in the Surgical Coaching for Operative Performance Enhancement (SCOPE) Program
Jason C Pradarelli, Steven Yule, Nikhil Panda, et al.
Breast Cancer Research : BCR
|
March 19, 2013
A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer
John F R Robertson, J Michael Dixon, D Mark Sibbering, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 27, 2009
Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia
Kelvin W Gee, Minhtam B Tran, Derk J Hogenkamp, et al.
British Journal of Cancer
|
February 21, 2019
MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer
Michael J G Milevskiy, Udai Gujral, Carolina Del Lama Marques, et al.
Page
of 39
Search research articles
Search
Showing results (331-340 of 383) with videos related to
Sort By:
Page
of 39
JAMA Surgery
|
October 14, 2020
Optimizing the Implementation of Surgical Coaching Through Feedback From Practicing Surgeons
Jason C Pradarelli, Steven Yule, Nikhil Panda, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 16, 2017
First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288
Kelvin W Gee, Ann Olincy, Richard Kanner, et al.
Annals of the New York Academy of Sciences
|
July 4, 2002
Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancer
R I Nicholson, I R Hutcheson, M E Harper, et al.
Journal of Surgical Education
|
November 4, 2022
Impact of Rater Training on Residents Technical Skill Assessments: A Randomized Trial
Kristen M Jogerst, Yoon Soo Park, Roi Anteby, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1997
CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat
D M Edgar, W F Seidel, K W Gee, et al.
Surgical Endoscopy
|
August 27, 2021
Challenges of virtual interviewing for surgical fellowships: a qualitative analysis of applicant experiences
Roi Anteby, Robert D Sinyard, Kristen M Jogerst, et al.
Annals of Surgery
|
August 3, 2020
Surgeons' Coaching Techniques in the Surgical Coaching for Operative Performance Enhancement (SCOPE) Program
Jason C Pradarelli, Steven Yule, Nikhil Panda, et al.
Breast Cancer Research : BCR
|
March 19, 2013
A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer
John F R Robertson, J Michael Dixon, D Mark Sibbering, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 27, 2009
Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia
Kelvin W Gee, Minhtam B Tran, Derk J Hogenkamp, et al.
British Journal of Cancer
|
February 21, 2019
MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer
Michael J G Milevskiy, Udai Gujral, Carolina Del Lama Marques, et al.
Page
of 39